Molyneux, Malcolm E (2017) 'New ethical considerations in vaccine trials.'. Human vaccines & immunotherapeutics, Vol 13, Issue 9, pp. 2160-2163.
|
Text
Hum_Vacc_Immun_Accepted_Version_MMolyneux.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial. Download (218kB) | Preview |
Abstract
Known and novel pathogens continue to afflict the world's population, and we deploy existing and new vaccines - the best type of weapon we've got - against them. One consequence is that we are accumulating steadily more experience of both the scientific and the ethical requirements of conducting vaccine trials in people. Good science is itself an ethical requirement, as it is meaningless to apply ethical principles to a scientifically flawed product or plan. Bad science can only be bad ethics. And we have learned that ethical principles are a necessity when we apply the benefits of science to the improving of human health.
Recent epidemics have provided opportunities to expand our understanding of this field and of the many components of it that we recognize to be necessary to the ethical assessment of vaccines.
Item Type: | Article |
---|---|
Subjects: | W General Medicine. Health Professions > W 50 Medical ethics QW Microbiology and Immunology > Reference Works. General Immunology > QW 520 Research (General) QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 805 Vaccines. Antitoxins. Toxoids QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 806 Vaccination |
Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
Digital Object Identifer (DOI): | https://doi.org/10.1080/21645515.2016.1272744 |
SWORD Depositor: | JISC Pubrouter |
Depositing User: | JISC Pubrouter |
Date Deposited: | 03 Mar 2017 15:58 |
Last Modified: | 17 Aug 2022 08:57 |
URI: | https://archive.lstmed.ac.uk/id/eprint/6802 |
Statistics
Actions (login required)
Edit Item |